COVID is 'pretty much out of the models' for pharma companies: Wells Fargo analyst

Some health companies' quarterly earnings were boosted by COVID-19 products in the past few years, and most are starting to see a shift away from pandemic profits for 2023. Wells Fargo analyst Mohit Bansal said as much about three companies reporting earnings this week: "COVID is pretty much out of the models. Pfizer (PFE) is probably the only one in our coverage where it is still a significant part of it because it was their biggest business last year."
Read more: https://news.yahoo.com/covid-is-pretty-much-out-of-the-models-for-pharma-companies-wells-fargo-analyst-232944434.html?source=Snapzu